How to Get Zepbound Without Insurance in 2026
Zepbound's list price is $1,059 per month, but almost no one pays that. The legitimate cash-pay paths bring it down to roughly $299–$349/month in May 2026, ranked by typical cost. Eli Lilly's LillyDirect self-pay vials are usually the cheapest path.
Cash-pay Zepbound paths at a glance
| Path | Monthly | Annual |
|---|---|---|
| Zepbound Savings Card (with commercial insurance) | ~$25 | ~$300 |
| Compounded tirzepatide via telehealth | $299 | $3,588 |
| LillyDirect self-pay vials (2.5 / 5 mg) | $349 | $4,188 |
| Branded Zepbound via telehealth | $499 | $5,988 |
| Cash retail (full WAC) | $1,059 | $12,708 |
1. Zepbound Savings Card (if you have commercial insurance)
If your commercial insurance covers Zepbound but the copay is high, the manufacturer Savings Card from Eli Lilly typically reduces the copay to around $25/month. Apply at zepbound.lilly.com.
See our full GLP-1 Savings Cards guide for both Wegovy and Zepbound program details, eligibility, and the government insurance exclusion.
2. LillyDirect self-pay vials ($349/mo, lower doses)
LillyDirect is Eli Lilly's direct-to-consumer storefront. The Zepbound vial product (currently 2.5 mg and 5 mg starting doses) is priced around $349 per month — a steep discount versus the auto-injector pen WAC of $1,059. The trade-off is a manual syringe draw rather than a pre-filled pen.
Higher doses (7.5 mg, 10 mg, 12.5 mg, 15 mg) are not in the LillyDirect self-pay vial menu. If you titrate above 5 mg and want to stay self-pay, the path is branded telehealth or, where legal, compounded tirzepatide.
Visit LillyDirect →3. Compounded tirzepatide (~$299/mo, where available)
Compounded tirzepatide is a personalized formulation made by a US-licensed 503A compounding pharmacy. The FDA officially ended the tirzepatide shortage in late 2024, narrowing the regulatory shield, but some 503A pharmacies continue to produce case-by-case formulations through licensed telehealth.
As of May 2026, expect availability and pricing to vary by state and platform. Range is typically $299-per-month. Avoid any "research-grade" or international peptide sources — those are not legal for human use.
4. Branded Zepbound via telehealth (~$499/mo)
If LillyDirect doses don't fit and compounded isn't available, branded Zepbound through telehealth typically runs around $499 per month including the prescriber visit and shipping.
Major options:
- Hims & Hers — fast onboarding, in-house pharmacy
- Ro — Body Program with coaching included
- Lemonaid Health — pay per visit
- LifeMD — wide GLP-1 menu
See our full telehealth provider comparison.
5. Run the comparison vs Wegovy and Mounjaro
Zepbound is usually the best $/lb-lost cash-pay GLP-1 because of its 22.5% peak weight loss in SURMOUNT-1 versus ~14.9% for Wegovy and lower for off-label Mounjaro. Run the math directly:
- Wegovy vs Zepbound — head-to-head
- Cheapest GLP-1 finder — all 8 drugs ranked
- How to Get Wegovy Without Insurance — parallel guide
Frequently asked questions
How much does Zepbound cost without insurance in 2026?
The list price (Wholesale Acquisition Cost) is $1,059 per 28-day supply, but almost no one pays that without coverage. The realistic cash-pay floor in May 2026 is roughly $299–$349 per month depending on how you source it: LillyDirect self-pay vials (lower doses), branded telehealth, or — where available — compounded tirzepatide.
What is LillyDirect and what does it offer for Zepbound?
LillyDirect is Eli Lilly's direct-to-consumer self-pay program. As of May 2026, it sells Zepbound vials (lower doses, 2.5 mg and 5 mg) starting around $349 per month. The auto-injector pen versions are not in the LillyDirect self-pay menu — they are only available through pharmacies under insurance or full WAC pricing. The vial format requires a manual draw with a syringe, which Lilly explicitly markets as the trade-off for the lower price.
Is the Zepbound savings card the same as LillyDirect?
No — they are two different programs from Eli Lilly. The Zepbound Savings Card reduces copay (often to ~$25) for patients whose commercial insurance already covers Zepbound. LillyDirect self-pay is for patients without coverage and is priced separately. Government insurance — Medicare, Medicaid, Tricare, VA — is excluded from the savings card by federal anti-kickback rules, but those patients can still use LillyDirect self-pay.
Is compounded tirzepatide still available in 2026?
Yes, but more limited than during the 2023–2024 boom. The FDA officially ended the tirzepatide drug shortage in late 2024, removing the regulatory shield for most compounded versions. As of May 2026, some 503A pharmacies still produce personalized tirzepatide formulations on a case-by-case basis through licensed telehealth, but availability and legal posture vary by state. Verify the pharmacy is US-licensed and PCAB-accredited; avoid international "research peptide" sources (not legal for human use).
Should I switch from Wegovy to Zepbound to save money?
Often yes, on cost-per-pound-lost basis. Zepbound trial efficacy is ~22.5% peak weight loss in SURMOUNT-1 versus ~14.9% for Wegovy in STEP-1, and the LillyDirect self-pay floor for Zepbound is comparable to or below NovoCare for Wegovy. So even when Zepbound costs slightly more per month, you tend to lose more weight per dollar. The /compare/wegovy-vs-zepbound page runs this side-by-side.
Does Mounjaro cash-pay save more than Zepbound?
Usually no, in 2026. Mounjaro (same molecule as Zepbound, FDA-approved for type 2 diabetes) does not have an equivalent of LillyDirect self-pay vials. Off-label cash-pay Mounjaro typically runs at full WAC or telehealth pricing, which is higher than Zepbound's LillyDirect floor. The exception: if you have type 2 diabetes and your insurance covers Mounjaro but not Zepbound, the diabetes-channel copay is the cheapest path.
Can I use a GoodRx coupon on Zepbound?
Coupons rarely beat LillyDirect or telehealth pricing. Zepbound is brand-name and patent-protected, so retail pharmacy cash prices are close to WAC even with coupons. GoodRx Care's telehealth subscription ($39/month) plus the pharmacy cost is occasionally competitive, but for most users LillyDirect self-pay is the cheaper path.
Stay ahead of every GLP-1 development
We'll email you when something actually matters: new FDA approvals (Foundayo, CagriSema, retatrutide), pricing drops at LillyDirect/NovoCare, telehealth deals, clinical trial results, FDA recalls, and insurance policy changes. ~1-2 emails/month. No filler.